Date published: 2026-5-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

SERPINF2 Inhibitors

Alpha-2 antiplasmin, also known as α-2-antiplasmin or plasmin inhibitor, is a serine protease inhibitor that plays a crucial role in regulating the activity of plasmin, an enzyme involved in blood clot dissolution (fibrinolysis). Specific small molecules that target α-2 antiplasmin or influence its activity directly or indirectly may have applications in fibrinolysis regulation or thrombosis management. SERPINF2 inhibitors belong to a chemical class of compounds that are designed to interact with and inhibit SERPINF2, also known as alpha-2 antiplasmin or plasmin inhibitor. SERPINF2 is a serine protease inhibitor that plays a critical role in regulating the activity of plasmin, a key enzyme involved in fibrinolysis, which is the process of breaking down blood clots. Plasmin degrades fibrin, the protein meshwork that forms blood clots, and its activity must be carefully controlled to excessive bleeding or, conversely, abnormal clot dissolution. SERPINF2 serves as a critical regulator in this process by binding to and inhibiting plasmin, thereby uncontrolled fibrinolysis.

Chemically, SERPINF2 inhibitors encompass a diverse range of compounds, including small organic molecules and synthetic analogs. These inhibitors are designed to interact with SERPINF2 in such a way that they disrupt its inhibitory activity against plasmin. By inhibiting SERPINF2, these compounds can indirectly enhance fibrinolysis and the dissolution of blood clots.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tranexamic acid

1197-18-8sc-204921
sc-204921A
5 g
10 g
$29.00
$50.00
10
(1)

Tranexamic acid is an antifibrinolytic agent that indirectly affects α-2 antiplasmin by preventing the degradation of fibrin clots. It inhibits the binding of plasminogen and plasmin to fibrin, reducing their fibrinolytic activity.

Aprotinin

9087-70-1sc-3595
sc-3595A
sc-3595B
10 mg
100 mg
1 g
$112.00
$408.00
$3000.00
51
(2)

Aprotinin is a protease inhibitor that can directly target and inhibit plasmin, thereby indirectly affecting α-2 antiplasmin by reducing the proteolytic degradation of fibrin and the subsequent release of α-2 antiplasmin from fibrin.